Literature DB >> 12642012

Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.

Carlos M Ferrario1.   

Abstract

Increased understanding of the contribution of angiotensin peptides to the physiologic control of arterial pressure and cardiovascular regulation has been made possible with the introduction of agents that either inhibit the activity of angiotensins forming enzymes or block the action of the peptides at their specific receptor subtypes. This review highlights some of the lessons that have been learned from the study of the actions of angiotensin-(1-7) and its inter-relationship with other vasodilator mechanisms that modulate the control systems that determine blood pressure and tissue perfusion. The studies suggest that the renin-angiotensin system acts as a humoral mechanism for blood pressure control through the generation of several distinct forms of angiotensin peptides that may bind to diverse receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642012     DOI: 10.1007/s11906-003-0069-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  45 in total

1.  Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.

Authors:  M A Oliveira; Z B Fortes; R A Santos; M C Kosla; M H De Carvalho
Journal:  Peptides       Date:  1999       Impact factor: 3.750

2.  Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis.

Authors:  R D Machado; R A Santos; S P Andrade
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-04       Impact factor: 3.619

3.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

4.  Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles.

Authors:  YiLin Ren; Jeffrey L Garvin; Oscar A Carretero
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

5.  Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature.

Authors:  R D P Machado; M A N D Ferreira; A V Belo; R A S Santos; S P Andrade
Journal:  Regul Pept       Date:  2002-07-15

Review 6.  Vasopeptidase inhibition: a new concept in blood pressure management.

Authors:  J C Burnett
Journal:  J Hypertens Suppl       Date:  1999-02

7.  Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.

Authors:  Zia Shariat-Madar; Fakhri Mahdi; Alvin H Schmaier
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

8.  Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension.

Authors:  Carlos M Ferrario; Ronald D Smith; Bridget Brosnihan; Mark C Chappell; Vito M Campese; Ole Vesterqvist; Wei-chi Liao; Michael C Ruddy; Clarence E Grim
Journal:  Am J Hypertens       Date:  2002-06       Impact factor: 2.689

9.  Converting enzyme determines plasma clearance of angiotensin-(1-7).

Authors:  K Yamada; S N Iyer; M C Chappell; D Ganten; C M Ferrario
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

10.  Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats.

Authors:  I F Benter; C M Ferrario; M Morris; D I Diz
Journal:  Am J Physiol       Date:  1995-07
View more
  7 in total

1.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

2.  Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.

Authors:  Minolfa C Prieto; Romer A González-Villalobos; Fady T Botros; Victoria L Martin; Javier Pagán; Ryousuke Satou; Lucienne S Lara; Yumei Feng; Fernanda B Fernandes; Hiroyuki Kobori; Dulce E Casarini; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-05

3.  Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells.

Authors:  Cheng Zhang; Yu Xia Zhao; Yue Hui Zhang; Li Zhu; Bi Ping Deng; Zhao Li Zhou; Shu Ying Li; Xiao Ting Lu; Li Li Song; Xue Ming Lei; Wen Bo Tang; Nan Wang; Chun Ming Pan; Huai Dong Song; Chun Xi Liu; Bo Dong; Yun Zhang; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

Review 4.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

5.  Intratubular Renin-Angiotensin System in Hypertension.

Authors:  Yuki Suzaki; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori
Journal:  Curr Hypertens Rev       Date:  2006

6.  Collecting Duct Renin: A major player in Angiotensin II-dependent Hypertension.

Authors:  Minolfa C Prieto-Carrasquero; Fady T Botros; Hiroyuki Kobori; L Gabriel Navar
Journal:  J Am Soc Hypertens       Date:  2009 Mar-Apr

7.  Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation.

Authors:  Vanesa Esteban; Silvia Heringer-Walther; Anja Sterner-Kock; Ron de Bruin; Sandra van den Engel; Yong Wang; Sergio Mezzano; Jesus Egido; Heinz-Peter Schultheiss; Marta Ruiz-Ortega; Thomas Walther
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.